 Enhancement erythrocytic adenosine deaminase treatment AIDS-related complex/AIDS patients zidovudine levels adenosine deaminase ADA erythrocytes patients infection cases AIDS-related complex ARC AIDS therapy zidovudine azidothymidine AZT linear increase ADA activity second third months zidovudine treatment final increase threefold months drug administration concentration adenosine triphosphate ATP erythrocytes group patients respect healthy controls decrease months zidovudine treatment results indicate treatment ARC/AIDS subjects zidovudine induces metabolic changes responsible development anaemia adverse effect zidovudine therapy